Related references
Note: Only part of the references are listed.ACG Clinical Guideline: Management of Irritable Bowel Syndrome
Brian E. Lacy et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2021)
Efficacy and safety of Bacillus coagulans LBSC in irritable bowel syndrome A prospective, interventional, randomized, double-blind, placebo-controlled clinical study [CONSORT Compliant]
Anil Kumar Gupta et al.
MEDICINE (2021)
Diagnosis and Treatment of Irritable Bowel Syndrome
Michael Camilleri
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Evidence-based clinical practice guidelines for irritable bowel syndrome 2020
Shin Fukudo et al.
JOURNAL OF GASTROENTEROLOGY (2021)
British Society of Gastroenterology guidelines on the management of irritable bowel syndrome
Dipesh H. Vasant et al.
GUT (2021)
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
Matthew J. Page et al.
PLOS MEDICINE (2021)
Impact of a Gastrointestinal Stable Probiotic SupplementBacillus coagulansLBSC on Human Gut Microbiome Modulation
Chiranjit Maity et al.
JOURNAL OF DIETARY SUPPLEMENTS (2021)
A 2-strain mixture of Lactobacillus acidophilus in the treatment of irritable bowel syndrome: A placebo-controlled randomized clinical trial
Stephane Sadrin et al.
DIGESTIVE AND LIVER DISEASE (2020)
Efficacy of Saccharomyces cerevisiae CNCM I-3856 as an add-on therapy for irritable bowel syndrome
Ravichandran Gayathri et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2020)
Lactobacillus acidophilus DDS-1 and Bifidobacterium lactis UABla-12 Improve Abdominal Pain Severity and Symptomology in Irritable Bowel Syndrome: Randomized Controlled Trial
Christopher J. Martoni et al.
NUTRIENTS (2020)
Global burden of irritable bowel syndrome: trends, predictions and risk factors
Christopher J. Black et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Heat-inactivated Bifidobacterium bifidum MIMBb75 (SYN-HI-001) in the treatment of irritable bowel syndrome: a multicentre, randomised, double-blind, placebo-controlled clinical trial
Viola Andresen et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis
Priya Oka et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
Bacillus coagulans and its applications in medicine
Y. Mu et al.
BENEFICIAL MICROBES (2019)
Second Asian Consensus on Irritable Bowel Syndrome
Kok Ann Gwee et al.
JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY (2019)
Randomized clinical trial: the effect of probiotic Bacillus coagulans Unique IS2 vs. placebo on the symptoms management of irritable bowel syndrome in adults
Ratna Sudha Madempudi et al.
SCIENTIFIC REPORTS (2019)
A meta-analysis of the use of probiotics to alleviate depressive symptoms
Qin Xiang Ng et al.
JOURNAL OF AFFECTIVE DISORDERS (2018)
The effect of Clostridium butyricum on symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial
Yi-Yuan Sun et al.
SCIENTIFIC REPORTS (2018)
Efficacy of Bacillus coagulans Unique IS2 in treatment of irritable bowel syndrome in children: a double blind, randomised placebo controlled study
M. Ratna Sudha et al.
BENEFICIAL MICROBES (2018)
Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R and Lactobacillus rhamnosus CLR2 improve quality-of-life and IBS symptoms: a double-blind, randomised, placebo-controlled study
K. Preston et al.
BENEFICIAL MICROBES (2018)
Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome
Alexander C. Ford et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Probiotic Bifidobacterium longum NCC3001 Reduces Depression Scores and Alters Brain Activity: A Pilot Study in Patients With Irritable Bowel Syndrome
Maria Ines Pinto-Sanchez et al.
GASTROENTEROLOGY (2017)
Bacillus As Potential Probiotics: Status, Concerns, and Future Perspectives
Fouad M. F. Elshaghabee et al.
FRONTIERS IN MICROBIOLOGY (2017)
Rome Criteria and a Diagnostic Approach to Irritable Bowel Syndrome
Brian E. Lacy et al.
JOURNAL OF CLINICAL MEDICINE (2017)
Bacillus coagulans MTCC 5856 supplementation in the management of diarrhea predominant Irritable Bowel Syndrome: a double blind randomized placebo controlled pilot clinical study
Muhammed Majeed et al.
NUTRITION JOURNAL (2016)
Randomized double blind placebo-controlled trial of Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: improvement in abdominal pain and bloating in those with predominant constipation
Robin Spiller et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2016)
Similar Fecal Microbiota Signatures in Patients With Diarrhea-Predominant Irritable Bowel Syndrome and Patients With Depression
Yixuan Liu et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
Efficacy of Lactobacillus casei Shirota for patients with irritable bowel syndrome
Annemieke Y. Thijssen et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2016)
Irritable bowel syndrome symptom severity improves equally with probiotic and placebo
Anna Lyra et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Irritable bowel syndrome, the microbiota and the gut-brain axis
Hans Raskov et al.
GUT MICROBES (2016)
Indigenous Bacteria from the Gut Microbiota Regulate Host Serotonin Biosynthesis
Jessica M. Yano et al.
CELL (2015)
A randomized clinical trial of Saccharomyces cerevisiae versus placebo in the irritable bowel syndrome
Guillaume Pineton de Chambrun et al.
DIGESTIVE AND LIVER DISEASE (2015)
The Intestinal Microbiota and Irritable Bowel Syndrome
Yehuda Ringel et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2015)
The microbiome may yield a new class of psychobiotics for the treatment of anxiety, depression and other mood disorders
Charles Schmidt
NATURE (2015)
Melatonin Regulation as a Possible Mechanism for Probiotic (VSL#3) in Irritable Bowel Syndrome: A Randomized Double-Blinded Placebo Study
Reuben K. Wong et al.
DIGESTIVE DISEASES AND SCIENCES (2015)
Lactobacillus acidophilus NCFM affects colonic mucosal opioid receptor expression in patients with functional abdominal pain-a randomised clinical study
T. Ringel-Kulka et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Anxiety and depression comorbidities in irritable bowel syndrome (IBS): a systematic review and meta-analysis
Guillaume Fond et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2014)
Cytokine and clinical response to Saccharomyces boulardii therapy in diarrhea-dominant irritable bowel syndrome: a randomized trial
Zaigham Abbas et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2014)
Randomized clinical trial: Effect of Lactobacillus plantarum 299 v on symptoms of irritable bowel syndrome
Cheryl Stevenson et al.
NUTRITION (2014)
Modulation of immunity and inflammatory gene expression in the gut, in inflammatory diseases of the gut and in the liver by probiotics
Julio Plaza-Diaz et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
A randomised controlled trial of a probiotic 'functional food' in the management of irritable bowel syndrome
Lesley M. Roberts et al.
BMC GASTROENTEROLOGY (2013)
Long-term treatment with probiotics in primary care patients with irritable bowel syndrome - a randomised, double-blind, placebo controlled trial
Luise Molenberg Begtrup et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2013)
A double-blind placebo-controlled trial to study therapeutic effects of probiotic Escherichia coli Nissle 1917 in subgroups of patients with irritable bowel syndrome
Wolfgang Kruis et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2012)
Efficacy and safety profile of LCR35 complete freeze-dried culture in irritable bowel syndrome: A randomized, double-blind study
Michel Dapoigny et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Clinical trial: Lactobacillus plantarum 299v (DSM 9843) improves symptoms of irritable bowel syndrome
Philippe Ducrotte et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life - a double-blind, placebo-controlled study
S. Guglielmetti et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
A Randomized, Double-blind, Placebo-controlled Multicenter Trial of Saccharomyces boulardii in Irritable Bowel Syndrome Effect on Quality of Life
Chang Hwan Choi et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2011)
Effects of probiotic fermented milk on symptoms and intestinal flora in patients with irritable bowel syndrome: A randomized, placebo-controlled trial
Bo Sondergaard et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2011)
A candidate probiotic with unfavourable effects in subjects with irritable bowel syndrome: a randomised controlled trial
Solveig C. Ligaarden et al.
BMC GASTROENTEROLOGY (2010)
A human gut microbial gene catalogue established by metagenomic sequencing
Junjie Qin et al.
NATURE (2010)
Clinical trial: the effects of a fermented milk product containing Bifidobacterium lactis DN-173 010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation
A. Agrawal et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Randomized Controlled Treatment Trial of Irritable Bowel Syndrome with a Probiotic E.-coli Preparation (DSM17252) Compared to Placebo
P. Enck et al.
ZEITSCHRIFT FUR GASTROENTEROLOGIE (2009)
Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhoea-predominant irritable bowel syndrome
J. Zeng et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Therapeutic effect of Lactobacillus acidophilus-SDC 2012, 2013 in patients with irritable bowel syndrome
Dong Hyun Sinn et al.
DIGESTIVE DISEASES AND SCIENCES (2008)
A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome
S. Drouault-Holowacz et al.
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE (2008)
Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota
K. Kajander et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care:: a multicentre, randomized, double-blind, controlled trial
D. Guyonnet et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors
Christel Rousseaux et al.
NATURE MEDICINE (2007)
Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome
Peter J. Whorwell et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
The efficacy of Lactobacillus reuteri ATCC 55730 in the treatment of patients with irritable bowel syndrome -: a double blind, placebo-controlled, randomized study
E Niv et al.
CLINICAL NUTRITION (2005)
A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating
HJ Kim et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2005)
A probiotic mixture alleviates symptoms in irritable bowel syndrome patients:: a controlled 6-month intervention
K Kajander et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
The use of Lactobacillus GG in irritable bowel syndrome in children:: A double-blind randomized control trial
M Bausserman et al.
JOURNAL OF PEDIATRICS (2005)
Lactobacillus and Bifidobacterium in irritable bowel syndrome:: Symptom responses and relationship to cytokine profiles
L O'Mahony et al.
GASTROENTEROLOGY (2005)
Clinical determinants of health-related quality of life in patients with irritable bowel syndrome
BMR Spiegel et al.
ARCHIVES OF INTERNAL MEDICINE (2004)
A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome
HJ Kim et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Health-related quality of life among persons with irritable bowel syndrome: a systematic review
HB El-Serag et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2002)
A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome
K Niedzielin et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2001)
Share Paper
